
At PROMISS Diagnostics they take applied science seriously. We believe marrying basic science with cutting-edge analytics can unleash exponential diagnostic potential from otherwise common blood tests. Their team is passionate about driving change and helping more people find hope by developing innovative diagnostic tools that are efficacious, inexpensive, and accessible to all.

At PROMISS Diagnostics they take applied science seriously. We believe marrying basic science with cutting-edge analytics can unleash exponential diagnostic potential from otherwise common blood tests. Their team is passionate about driving change and helping more people find hope by developing innovative diagnostic tools that are efficacious, inexpensive, and accessible to all.
Location & founding: Founded November 2017; HQ Wauwatosa / Milwaukee, Wisconsin
Headcount: About 10 employees
Product: PROMISS — ML-driven, multi-analyte blood diagnostic for ovarian cancer
Clinical status: Undergoing multicenter clinical validation
Seed funding: $400,000 seed round announced Jan 9, 2020
Early detection and diagnostic differentiation of ovarian masses / ovarian cancer
2017
Biotechnology / Diagnostics
$400,000
Additional investment from Cream City Venture Capital (Northwestern Mutual)
“WARF-led seed round with participation from regional corporate VC”